Combinatorial derivatives of oligopeptides having antiviral properties

Abstract

The invention relates to organic and bio-organic combinatorial chemistry, specifically to new combinatorial libraries of oligopeptide derivatives and supra molecular structures based thereon that have powerful antiviral properties when used without being separated into individual components. The aim of the invention is to synthesize combinatorial oligopeptide derivatives that have antiviral properties and a new mechanism of action and that can be used to significantly improve treatment effectiveness and reduce treatment duration in the case of viral diseases such as influenza and herpesvirus infections. This aim is achieved by synthesizing combinatorial oligopeptide derivatives having antiviral properties, characterized in that the combinatorial oligopeptide derivatives, in the structure of which lysine, histidine, and arginine amino groups as well as serine and threonine alcoholic residues are available for modification, are simultaneously combinatorially modified by at least two different covalent modifiers, and subsequently the resulting combinatorial mixture is used whole, without purification and without separation of each individual derivative, as an antiviral agent in various pharmaceutical compositions. The result is modified complementary protected oligopeptides that have powerful antiviral properties and on the basis of which a medicinal, veterinary, or cosmetic product having a broad spectrum of activity can be obtained. The agent has a broad spectrum of action and low toxicity, and is suitable for industrial production.

Dependencies are inferred from the claim text.